Literature DB >> 11246126

Species and organ specificity of fumonisin-induced endothelial alterations: potential role in porcine pulmonary edema.

L A Gumprecht1, G W Smith, P C Constable, W M Haschek.   

Abstract

Fumonisins, mycotoxins that commonly contaminate corn, induce cardiovascular toxicity and pulmonary edema in pigs, leukoencephalomalacia in horses, and nephropathy in rats, rabbits, and lambs. The mechanisms of these species-specific target organ toxicoses are poorly understood. We have previously reported perinuclear accumulation of membranous material in pulmonary capillary endothelial cells of pigs fed fumonisin-containing culture material. We hypothesized that these endothelial accumulations may be important in the pathogenesis of fumonisin-induced pulmonary edema and target organ toxicity in other species. Both target and non-target tissues from fumonisin-exposed pigs, sheep, rabbits, and rats were examined ultrastructurally. Specifically, lung, liver, heart and kidney were examined. In agreement with our previous work (Gumprecht, L.A., Beasley, V.R., Weigel, R.M., Parker, H.M., Tumbleson, M.E., Bacon, C.W., Meredith, F.I., Haschek, W.M., 1998. Development of fumonisin-induced hepatotoxicity and pulmonary edema in orally dosed swine: morphological and biochemical parameters. Tox. Pathol. 26, 777-788), endothelial alterations were present in the pulmonary capillary endothelial cells of pigs fed fumonisin-containing culture material, but at doses that did not induce pulmonary edema, as well as in pigs injected intravenously with purified fumonisin B(1). These alterations were present only in the pulmonary capillary endothelium of pigs and not in other species. In addition, these endothelial alterations were not present in any other organ of pigs or other species examined. Thus, these endothelial alterations are induced by fumonisin B(1), but only in pulmonary capillary endothelium and only in pigs. Although evidence that these alterations play a role in fumonisin-induced pulmonary edema is limited, other endothelial functions may be affected by fumonisin treatment.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11246126     DOI: 10.1016/s0300-483x(00)00444-3

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  6 in total

1.  Intoxication with fumonisin B1 (FB1) in piglets and supplementation with granulated activated carbon: cellular-mediated immunoresponse.

Authors:  E Cabassi; F Miduri; A M Cantoni
Journal:  Vet Res Commun       Date:  2005-08       Impact factor: 2.459

Review 2.  Fumonisin toxicosis in swine: an overview of porcine pulmonary edema and current perspectives.

Authors:  W M Haschek; L A Gumprecht; G Smith; M E Tumbleson; P D Constable
Journal:  Environ Health Perspect       Date:  2001-05       Impact factor: 9.031

Review 3.  Fusarium Molds and Mycotoxins: Potential Species-Specific Effects.

Authors:  Alessia Bertero; Antonio Moretti; Leon J Spicer; Francesca Caloni
Journal:  Toxins (Basel)       Date:  2018-06-15       Impact factor: 4.546

4.  Fumonisin B1 Induces Oxidative Stress and Breaks Barrier Functions in Pig Iliac Endothelium Cells.

Authors:  Qiaoling Yuan; Yancheng Jiang; Ying Fan; Yingfeng Ma; Hongyu Lei; Jianming Su
Journal:  Toxins (Basel)       Date:  2019-07-02       Impact factor: 4.546

5.  Biomarker Evaluation and Toxic Effects of an Acute Oral and Systemic Fumonisin Exposure of Pigs with a Special Focus on Dietary Fumonisin Esterase Supplementation.

Authors:  Hanna Schertz; Sven Dänicke; Jana Frahm; Dian Schatzmayr; Ilse Dohnal; Gerlinde Bichl; Heidi E Schwartz-Zimmermann; Sonia Colicchia; Gerhard Breves; Jens P Teifke; Jeannette Kluess
Journal:  Toxins (Basel)       Date:  2018-07-17       Impact factor: 4.546

6.  Fumonisin B1 Inhibits Cell Proliferation and Decreases Barrier Function of Swine Umbilical Vein Endothelial Cells.

Authors:  Qing Li; Qiaoling Yuan; Tianjie Wang; Yang Zhan; Lingchen Yang; Ying Fan; Hongyu Lei; Jianming Su
Journal:  Toxins (Basel)       Date:  2021-12-03       Impact factor: 4.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.